Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Study ID: NCT06035120

Sponsor

Pulmonx Corporation

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Study ID: NCT03500731

Sponsor

Paul Szabolcs

Accelerated Pulmonary Rehabilitation in the Preoperative Period

Study ID: NCT06432972

Sponsor

University of Vermont

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Study ID: NCT06271408

Sponsor

Polarean, Inc.

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Study ID: NCT05306743

Sponsor

Observational and Pragmatic Research Institute

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema

Study ID: NCT04801108

Sponsor

Beth Israel Deaconess Medical Center

The ROAM Research Study Therapy (LTOT) Version

Study ID: NCT06810323

Sponsor

University of Virginia

Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

Study ID: NCT04069312

Sponsor

Johns Hopkins University

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Study ID: NCT04636814

Sponsor

Chiesi Farmaceutici S.p.A.

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Study ID: NCT06959095

Sponsor

GlaxoSmithKline